Cyclin E expression and chemotherapeutic sensitivity in breast cancer cells

Abstract

The effects of the cyclin E expression levels on chemotherapeutic sensitivity of breast cancer cell line were explored. After the cyclin E expression was knockdown in MDA-MB-435 by RNA interference, FACS analysis and SA-β-gal staining were used to evaluate the response sensitivity of breast cancer cells to DNA damage drugs (adriamycin, etc.). Adriamycin could induce G1 arrest in cyclin E knockdown MDA-MB-435 breast cell line and increase the percentage of cell senescence in cyclin E knockdown MDA-MB-435 cells. It was suggested that cyclin E knockdown could increase the chemotherapeutic sensitivity of breast cancer cells to DNA damage drugs.

Keywords

cyclin E / DNA damage / RNA interference / breast cancer cell

References

[1] LiK., LinS. Y., BrunicardiF. C., et al.. Use of RNA interference to target cyclin E overexpressing hepatocellular carcinoma. Cancer Res, 2003, 63: 3593-3597

[2] DimriG. P., XinhuaL., BasileG., et al.. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA, 1995, 92: 9363-9367

[3] HuntK. K., KeyomarsiK.. Cyclin E as a prognostic and predictive marker in breast cancer. Semi Cancer Biol, 2005, 15: 319-326

[4] CampisiJ.. Cellular senescence as a tumor-suppressor mechanism. Trends Cell Biol, 2001, 11: 27-31

[5] te PoeleR. H., OkorokovA. L., JardineL., et al.. DNA damage is able to induce senescence in tumor cells in vitro and in vivo. Cancer Res, 2002, 62: 1876-1883